Biocon Ltd News Today

Yesintek has been added to Express Scripts' National Preferred Formulary (NPF), effective March 21, 2025.

The fundraising may be executed in one or more tranches using QIP, rights issues, or any other permissible route under regulatory guidelines.

Here are some of the stocks that may see significant price movement today: LTIMindtree, Dalmia Bharat, Bajaj Housing, etc.

Jobevne is a vascular endothelial growth factor (VEGF) impediment that sticks with VEGF and restrain the interaction with its receptors.

The first approval is for the 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg strengths of Lenalidomide Capsules.

Civica will start selling the medicine for patients in the United States after completing development work and clinical trials.

The drug is also used to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) in adults who have shown resistance or intolerance to prior therapy.

Biocon will market Liraglutide under two brand names - Liraglutide Biocon for diabetes, which is a generic version of Victoza.

As per the company, YESINTEK shall be available in all the same formulations currently provided by Stelara.

Here are some of the stocks that may see significant price movement today: Biocon, NTPC Green Energy, LIC, etc.